March 2018 : Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE
March 2018 : Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE
See the article
March 2018 – 10-year report on the European Paediatric Regulation and its impact on new drugs for children’s cancers
March 2018 – 10-year report on the European Paediatric Regulation and its impact on new drugs for children’s cancers
See the article
August 2017 – Orphan Drug Regulation : a missed opportunity for children and adolescents with cancer
August 2017 – Orphan Drug Regulation : a missed opportunity for children and adolescents with cancer
EJC – august 2017 See the article
September 2016 – New medicines against pediatric cancers : what must be done in Europe
September 2016 – New medicines against pediatric cancers : what must be done in Europe
parue dans la Revue d’hématologie oncologie pédiatrique Auteurs: Pr Gilles Vassal & Patricia Blanc VOIR L’ARTICLE
January 2016 – How and which conditions to develop new anti-cancer medicines in pediatrics?
January 2016 – How and which conditions to develop new anti-cancer medicines in pediatrics?
Vol.65. Co-auteurs : Jean-Claude DUPONT, Patricia BLANC, François DOZ. VOIR L’ARTICLE
September 2015 – Will the revisited class waiver list make it ?
September 2015 – Will the revisited class waiver list make it ?
March 2015 – For specific research against children’s cancers: how the association Imagine for Margo goes into action
March 2015 – For specific research against children’s cancers: how the association Imagine for Margo goes into action
November 2014 – Creating a unique multi-stakeholder paediatric oncology platform to improve drug development for children and adolescents with cancer
November 2014 – Creating a unique multi-stakeholder paediatric oncology platform to improve drug development for children and adolescents with cancer
